Articles

Quantum-computing stocks sink as Nvidia CEO delivers a reality check

Shares of Rigetti Computing, Quantum Computing, IonQ and D-Wave were down sharply after Nvidia’s Jensen Huang said that “very simple quantum computers” could be 20 years away.

AMD is going head-to-head with Nvidia in AI-backed drug discovery with new deal

Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

‘I’m semi-retired and working about 20 hours a month’: With congestion charges, insurance and gas prices — is it time to become a one-car family?

“I’m considering downsizing to one car to save about $1,600 a year.”

Cannabis companies say DEA has closed mind against a less-dangerous pot ranking

Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under the Controlled Substances Act.

Jobless claims fall to a nearly one-year low as Trump set to take office

The number of people who applied for unemployment benefits in the first week of the new year fell to an 11-month low, the latest sign layoffs remain extremely low even as businesses cut back on hiring.

Fed’s Waller backs more rate cuts, says he doesn’t think proposed Trump tariffs will spark inflation

Federal Reserve Governor Christopher Waller said Wednesday that he doesn’t think that proposed import tariffs from the incoming Trump administration will lead to upward pressure on inflation.

Albertsons profit beat overshadows a sales miss as it readies to go it alone

Albertsons Cos. Inc.’s stock rose 3.6% early Wednesday, after the grocery chain beat profit estimates for its fiscal third quarter, offsetting a small revenue miss.

Here are the ways bulls believe that January can tell the stock market’s future

Looking for signs from the “first five days of January indicator” and the “January barometer.”

Private equity in 401(k) plans? ‘Highly risky’ for the average investor

The private-equity industry wants more access to retirement accounts.

How to hedge the ‘permanently higher’ inflation Trump’s policies could ignite

This fund manager recommends dividend-paying stocks in three sectors that stand to benefit from rising prices.

Exxon Mobil warns that lower oil prices and tighter refining margins will weigh on earnings

Post Content

Ozempic maker Novo Nordisk, after trial disappointment, expands AI deal in potential $4.6 billion pact

At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish drugmaker reported disappointing results for its next-generation weight-loss drug.
1 143 144 145 146 147 1,957